Psoralen Plus UVA Induces Local IFN Production and Antitumor Responses in Cutaneous T-Cell Lymphoma

J Invest Dermatol. 2024 Mar;144(3):449-450. doi: 10.1016/j.jid.2023.08.029. Epub 2023 Nov 3.

Authors

Rishi R Goel¹, Alain H Rook²

Affiliations

¹ Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Institute for Immunology and Immune Health (I3H), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: [email protected].

PMID: 37921716
DOI: 10.1016/j.jid.2023.08.029

No abstract available

MeSH terms

Ficusin / therapeutic use
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
PUVA Therapy
Skin Neoplasms* / drug therapy

Substances

Ficusin